Dr. Dylan K Chan, MD, PhD

Claim this profile

UCSF Benioff Children's Hospital

Studies Hearing Loss
Studies Sensorineural Hearing Loss
3 reported clinical trials
4 drugs studied

Affiliated Hospitals

Image of trial facility.
The University Of California, San Francisco
Image of trial facility.
UCSF-Benioff Children's Hospital

Clinical Trials Dylan K Chan, MD, PhD is currently running

Image of trial facility.

Hearing Screening

for Childhood Hearing Loss

Children who are deaf or hard-of-hearing (D/HH) are at risk of speech and language delays, which can be mitigated through early identification and intervention. Identifying hearing loss (HL) during preschool is crucial, but the most effective hearing screening method for preschoolers remains uncertain. The purpose of this study is to learn whether, compared to the gold-standard two-stage Pure-tone audiometry (PTA) + otoacoustic emissions (OAE) screening (TS-PO), single-stage OAE (SS-O) screening alone is not inferior at identifying hearing loss when performed in a community-based preschool setting. This study holds the potential to improve early hearing loss detection and intervention among D/HH children, reducing the likelihood of speech and language delays. A diverse group of 28,000 preschool-age children across community-based preschool centers will be recruited. The intervention involves all subjects undergoing both PTA and OAE screening, with the order determined through randomization. Children who show potential hearing issues based on screening results or teacher concerns will receive further testing to determine the final hearing outcome. Group allocation will be post-hoc, based on their screening results. In addition to the primary objective, the study will compare other hearing screening measures and outcomes between the two methods (TS-PO and SS-O). This approach aims to reflect the real-life effectiveness of hearing screening in a diverse population. Ultimately, the study seeks to provide insights into an optimal hearing screening method that could prevent speech and language delays among D/HH children.
Recruiting1 award N/A2 criteria

More about Dylan K Chan, MD, PhD

Clinical Trial Related6 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Dylan K Chan, MD, PhD has experience with
  • Otoacoustic Emissions Testing
  • Pure Tone Audiometry
  • Speech-Language Teletherapy
  • Valganciclovir

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dylan K Chan, MD, PhD specialize in?
Dylan K Chan, MD, PhD focuses on Hearing Loss and Sensorineural Hearing Loss. In particular, much of their work with Hearing Loss has involved treating patients, or patients who are undergoing treatment.
Is Dylan K Chan, MD, PhD currently recruiting for clinical trials?
Yes, Dylan K Chan, MD, PhD is currently recruiting for 1 clinical trial in San Francisco California. If you're interested in participating, you should apply.
Are there any treatments that Dylan K Chan, MD, PhD has studied deeply?
Yes, Dylan K Chan, MD, PhD has studied treatments such as Otoacoustic Emissions Testing, Pure Tone Audiometry, Speech-Language Teletherapy.
What is the best way to schedule an appointment with Dylan K Chan, MD, PhD?
Apply for one of the trials that Dylan K Chan, MD, PhD is conducting.
What is the office address of Dylan K Chan, MD, PhD?
The office of Dylan K Chan, MD, PhD is located at: UCSF Benioff Children's Hospital, San Francisco, California 94158 United States. This is the address for their practice at the UCSF Benioff Children's Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.